Molina Healthcare Files 8-K on Financial Results & Condition

Ticker: MOH · Form: 8-K · Filed: Feb 7, 2024 · CIK: 1179929

Molina Healthcare, Inc. 8-K Filing Summary
FieldDetail
CompanyMolina Healthcare, Inc. (MOH)
Form Type8-K
Filed DateFeb 7, 2024
Risk Levellow
Pages2
Reading Time2 min
Key Dollar Amounts$0.001
Sentimentneutral

Complexity: simple

Sentiment: neutral

Topics: financial-results, 8-K, corporate-filing

TL;DR

**Molina Healthcare just dropped an 8-K on financial results, get ready for potential stock movement.**

AI Summary

Molina Healthcare, Inc. filed an 8-K on February 7, 2024, to report its financial results and condition, specifically under Item 2.02 and Item 9.01. This filing indicates that the company is providing an update on its operations, which is crucial for investors to understand the company's current financial health and performance. For shareholders, this matters because it offers transparency into Molina's profitability and stability, directly influencing stock valuation and future investment decisions.

Why It Matters

This filing provides investors with the latest financial performance data for Molina Healthcare, Inc., enabling them to assess the company's health and make informed investment decisions.

Risk Assessment

Risk Level: low — This 8-K is a routine disclosure of financial results, which is standard for public companies and does not inherently signal high risk.

Analyst Insight

Investors should review the full financial statements and exhibits referenced in Item 9.01 once they become available to understand the specifics of Molina Healthcare's financial performance and condition.

Key Numbers

  • 1-31719 — Commission File Number (identifies the company's registration with the SEC)
  • 13-4204626 — IRS Employer Identification No. (identifies the company for tax purposes)
  • $0.001 — Par Value per share (the nominal value of Molina Healthcare's Common Stock)

Key Players & Entities

  • MOLINA HEALTHCARE, INC. (company) — the registrant filing the 8-K
  • New York Stock Exchange (company) — where Molina Healthcare's Common Stock is registered
  • February 7, 2024 (date) — date of earliest event reported and filing date
  • Delaware (company) — state of incorporation for Molina Healthcare, Inc.
  • 001-31719 (dollar_amount) — Commission File Number

FAQ

What is the purpose of this 8-K filing by Molina Healthcare, Inc.?

Molina Healthcare, Inc. filed this 8-K to report on its Results of Operations and Financial Condition (Item 2.02) and to provide Financial Statements and Exhibits (Item 9.01), as indicated by the 'ITEM INFORMATION' sections in the filing.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing occurred on February 7, 2024, as stated in the 'Date of Report (Date of earliest event reported): February 7, 2024' section.

Where is Molina Healthcare, Inc. incorporated?

Molina Healthcare, Inc. is incorporated in Delaware, as specified in the filing under 'Delaware (State or other jurisdiction of incorporation)'.

What is the trading symbol for Molina Healthcare, Inc.'s Common Stock and on which exchange is it registered?

The trading symbol for Molina Healthcare, Inc.'s Common Stock is MOH, and it is registered on the New York Stock Exchange, as detailed under 'Securities registered pursuant to Section 12(b) of the Act'.

What is Molina Healthcare, Inc.'s business address?

Molina Healthcare, Inc.'s business address is 200 Oceangate, Suite 100, Long Beach, California 90802, with a business phone number of (562) 435-3666, according to the 'BUSINESS ADDRESS' section of the filing.

Filing Stats: 542 words · 2 min read · ~2 pages · Grade level 10.3 · Accepted 2024-02-07 16:18:44

Key Financial Figures

  • $0.001 — ange on which registered Common Stock, $0.001 Par Value MOH New York Stock Exchange

Filing Documents

02. Results of Operations and Financial Condition

Item 2.02. Results of Operations and Financial Condition. On February 7, 2024, Molina Healthcare, Inc. (the "Company") issued a press release reporting its financial results for the fourth quarter and year ended December 31, 2023 and the Company's full-year 2024 revenue and earnings guidance. The full text of the press release is included as Exhibit 99.1 to this report. The information contained in the Company's website cited in the press release is not part of this report. Note: The information in this Form 8-K and the exhibits attached hereto shall not be deemed to be "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such a filing.

01. Financial Statements and Exhibits

Item 9.01. Financial Statements and Exhibits. (d) Exhibits: Exhibit No. Description 99.1 Press release of Molina Healthcare, Inc., issued February 7, 2024. 104 Cover Page Interactive Data File (embedded within the Inline XBRL document)

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. MOLINA HEALTHCARE, INC. Date: February 7, 2024 By: /s/ Jeff D. Barlow Jeff D. Barlow Chief Legal Officer and Secretary

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.